Nanopath
About:
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
Website: https://www.nanopathdx.com/
Twitter/X: nanopathdx
Top Investors: Alumni Ventures, National Science Foundation, Norwest Venture Partners, National Institutes of Health, Green D Ventures
Description:
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
Total Funding Amount:
$14.3M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2019-01-01
Founders:
Alison Burklund, Amogha Tadimety
Number of Employees:
11-50
Last Funding Date:
2024-05-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai